BLOONIS Trademark

Trademark Overview

On Thursday, January 10, 2008, a trademark application was filed for BLOONIS with the United States Patent and Trademark Office. The USPTO has given the BLOONIS trademark a serial number of 79049610. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, January 11, 2018. This trademark is owned by sanofi-aventis. The BLOONIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancers
bloonis

General Information

Serial Number79049610
Word MarkBLOONIS
Filing DateThursday, January 10, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, January 11, 2018
Registration Number3493011
Registration DateTuesday, August 26, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 10, 2008

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of cancers

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 27, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party Namesanofi-aventis
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party Namesanofi-aventis
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, July 27, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, July 27, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, October 21, 2016TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, February 13, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, February 13, 2016INVALIDATION PROCESSED
Friday, November 27, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 27, 2015CANCELLED SECTION 71
Sunday, March 31, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, July 21, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, December 11, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, December 19, 2008FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 19, 2008FINAL DISPOSITION PROCESSED
Thursday, November 27, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 26, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, June 10, 2008PUBLISHED FOR OPPOSITION
Wednesday, May 21, 2008NOTICE OF PUBLICATION
Thursday, May 8, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 7, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 28, 2008APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 28, 2008ASSIGNED TO LIE
Thursday, April 24, 2008PAPER RECEIVED
Monday, April 21, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 21, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 21, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 21, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 21, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 11, 2008REFUSAL PROCESSED BY IB
Wednesday, March 19, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 19, 2008REFUSAL PROCESSED BY MPU
Wednesday, March 19, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 18, 2008NON-FINAL ACTION WRITTEN
Friday, March 14, 2008ASSIGNED TO EXAMINER
Friday, March 7, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, March 6, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

bloonis cancers treatment prevention products pharmaceutical